期刊文献+

REV3基因rs12211763、rs465646与宁夏汉族人群结直肠癌的关联性研究 被引量:1

The Association between rs12211763,rs465646 of REV3 Genes and Colorectal Cancer in Han Population of Ningxia
下载PDF
导出
摘要 目的探讨REV3基因rs12211763和rs465646与宁夏汉族人群结直肠癌(colorectal cancer,CRC)易感性的关系。方法采用聚合酶链反应-限制性片段长度多态性(polymerase chain reaction-restriction fragment length polymorphism,PCR-RFLP)方法对204例CRC患者和207例对照的REV3基因rs12211763和rs465646进行基因分型,并通过SHEsis在线软件构建单倍型。结果 rs12211763、rs465646的基因型和等位基因频率在病例组和对照组间无统计学差异(P>0.05)。按肿瘤发生部位进行分层分析后,两位点的基因型频率在结肠癌组和对照组间、直肠癌组和对照组间的差异均无统计学差异(P>0.05)。rs12211763、rs465646的单倍型频率在病例组和对照组间无统计学差异(P>0.05)。结论 REV3基因的rs12211763和rs465646可能与宁夏汉族人群结直肠癌的遗传易感性无关。 Objective to investigate the correlation between rs12211763,rs465646 of REV3 gene and susceptibility of colorectal cancer( CRC) in Han population of Ningxia. Methods rs12211763 and rs465646 of REV3 gene were genotyped by Polymerase Chain Reaction- Restriction Fragment Length Polymorphism( PCR- RFLP) method in 204 CRCs and 207 controls,and the haplotypes were created by SHEsis online software. Results Genotype and allele frequency distribution of rs12211763,rs465646 between cases and controls had no statistically significant difference( P〉0. 05). After stratification from the cancer location,the genotype frequency distributions of two polymorphisms,colon cancer and rectal cancer patients with that in controls,had no statistically significant difference( P〉0. 05). The haplotype distributions derived from rs12211763 and rs465646 didn't have significant difference between the two groups( P〉0. 05). Conclusion rs12211763 and rs465646 of REV3 may have no relationship with the susceptibility of CRC.
出处 《宁夏医科大学学报》 2015年第1期4-8,F0004,共6页 Journal of Ningxia Medical University
基金 国家自然科学基金(31360251) 宁夏回族自治区教育厅宁夏高等学校科学技术研究项目(NGY2014085)
关键词 结直肠癌 REV3 单核苷酸多态性 colorectal cancer REV3 single nucleotide polymorphisms
  • 相关文献

参考文献11

  • 1Pardini B, Kumar R, Naccarati A, et al. MTHFR and MTRR genotype and haplotype analysis and colorectal cancer susceptibility in a case - control study from the Czech Republic [ J ]. Mutation research, 2011,721 (1) :74 -80.
  • 2陈万青,张思维,曾红梅,郑荣寿,邹小农,赵平,吴良有,李光琳,赫捷.中国2010年恶性肿瘤发病与死亡[J].中国肿瘤,2014,23(1):1-10. 被引量:882
  • 3Brondello JM, Pillaire M J, Rodriguez C, et al. Novelevidences for a tumor suppressor role of Rev3, the cat- alytic subunit of Pol zeta [ J ]. Oneogene, 2008,27 (47) :6093 - 101.
  • 4隋御,李元杰,金彩霞,徐方.REV3基因对结肠癌细胞遗传信息表达的影响[J].遗传,2010,32(5):467-472. 被引量:4
  • 5隋御,李元杰,黄金娟,徐方.REV3基因低表达对COLO-205细胞增殖的影响[J].宁夏医科大学学报,2012,34(6):572-575. 被引量:2
  • 6Wittschieben JP, Reshmi SC, Gollin SM, et al. Loss of D~A polymerase zeta causes chromosomal instability in mammalian ceils [ J ]. Cancer Res, 2006,66 ( 1 ) : 134 - 142.
  • 7Wittschieben JP, Patil V, Glushets V, et al. Loss of DNA polymerase zeta enhances spontaneous tumorigen- esis[ J ]. Cancer Res,2010,70(7) :2770 - 2778.
  • 8Varadi V, Bevier M, Grzybowska E, et al. Genetic variation in genes encoding for polymerase zeta sub-units associates with breast cancer risk, tumour char- acteristics and survival [ J ]. Breast cancer research and treatment,2011,129 ( 1 ) : 235 - 245.
  • 9Pan J, Chi P, Lu X, et al. Genetic polymorphisms in translesion synthesis genes are associated with colorec- tal cancer risk and metastasis in Han Chinese [J]. Gene,2012,504(2) : 151 - 155.
  • 10Zhang S, Chen H, Zhao X, et al. REV3L 3UTR 460 T > C polymorphism in microRNA target sites contrib- utes to lung cancer susceptibility [ J ]. Oncogene, 2013,32 (2) :242 - 250.

二级参考文献46

  • 1郑树.我国结直肠癌研究现状[J].实用肿瘤杂志,1996,11(3):97-99. 被引量:15
  • 2马玉彦,王波,鄢德友,刘理,李殿俊,林英姬,娄阁,王惠增,陈国林.MTT法检测人实体瘤化疗敏感性的临床应用研究[J].实用肿瘤学杂志,1996,10(4):9-10. 被引量:13
  • 3Kang H, outcomes carcinoma 2005, 48 : O' Connell JB, Maggard MA, et al. A 10-year evaluation of mucinous and signet ring cell of the colon and rectum. Dis Colon Rectum, 1161-1168.
  • 4Kanemitsu Y, Kato T, Hirai T, et ai. Survival after curative resection for mutinous adenocarcinoma of the colorectum. Dis Colon Rectum, 2003,46 : 160-167.
  • 5Longo R, Morabito A, Carillio G, et al. Muhiorganic dissemination of a colorectal signet ring cell carcinoma with fulminant clinical course. Int J Gastrointest Cancer, 2006, 37,49-54.
  • 6Maksimovie S. Survival rates of patients with mucinous adenocareinoma of the colorectum. Med Arh, 2007, 61 : 26- 29.
  • 7Nozoe T, Anai H, Nasu S, et al. Ctinicopathological characteristics of mutinous carcinoma of the colon and rectum. J Surg Oneol, 2000,75 : 103-107.
  • 8Human colorectal cancer. The Mouse Models of Human Cancers Consortium (MMHCC) Cancer Models Data- base. Available at: http:// emice, nci. nih. gov/emice/mouse_ models/organ_ models/gastro models/human_ colorectal_ cancer. :2008.
  • 9Younes M, Katikaneni PR, Lechago J. The value of the preoperative mucosal biopsy in the diagnosis of coloreetal mueinous adenocarcinoma. Cancer, 1993,72:3588-3592.
  • 10Du W, Mah JT, Lee J, et al. Incidence and survival of mucinous adenocarcinoma of the colorectum: a populationbased study from an Asian country. Dis Colon Rectum, 2004, 47:78-85.

共引文献890

同被引文献1

  • 1Shigeo Koido,Toshifumi Ohkusa,Sadamu Homma,Yoshihisa Namiki,Kazuki Takakura,Keisuke Saito,Zensho Ito,Hiroko Kobayashi,Mikio Kajihara,Kan Uchiyama,Seiji Arihiro,Hiroshi Arakawa,Masato Okamoto,Jianlin Gong,Hisao Tajiri.Immunotherapy for colorectal cancer[J].World Journal of Gastroenterology,2013,19(46):8531-8542. 被引量:11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部